Inhibition of Interleukin 2 (IL-2)-stimulated tyrosine kinase activity by leflunomide

Daniel A Nikcevich, Alison Finnegan, Anita S.F. Chong, James W. Williams, Eric G. Bremer

Research output: Contribution to journalArticlepeer-review

23 Scopus citations


We have used antigen-specific T-cell clones plus antigen to examine the biochemical effects of leflunomide on T cells during an immune response. Leflunomide inhibited both antigen and IL-2-stimulated proliferation of these clones, with an ED50 of 8-10 μM for either stimuli. Conversely, antigen-stimulated cytokine production and up-regulation of the IL-2 receptor (CD25) were relatively insensitive to inhibition by leflunomide. IL-2-receptor-mediated signaling, however, was inhibited by this drug. Using32P-orthophosphate metabolic labeling and anti-phosphotyrosine immunoprecipitation, we were able to show that leflunomide inhibited IL-2-stimulated tyrosine kinase activity. Furthermore, we demonstrated that leflunomide directly inhibited the IL-2 stimulated tyrosine kinase activity of p56lck. These data suggest that inhibition of IL-2-stimulated p56lck activity could play a role in leflunomide-mediated immunosuppression.

Original languageEnglish (US)
JournalAgents and Actions
Issue number2 Supplement
StatePublished - Aug 1 1994

Fingerprint Dive into the research topics of 'Inhibition of Interleukin 2 (IL-2)-stimulated tyrosine kinase activity by leflunomide'. Together they form a unique fingerprint.

Cite this